SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093880
Filing Date
2024-08-08
Accepted
2024-08-08 16:05:27
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20240630.htm   iXBRL 10-Q 1951660
2 EX-10.1 ikna-ex10_1.htm EX-10.1 8905
3 EX-10.2 ikna-ex10_2.htm EX-10.2 8385
4 EX-31.1 ikna-ex31_1.htm EX-31.1 16054
5 EX-31.2 ikna-ex31_2.htm EX-31.2 16141
6 EX-32.1 ikna-ex32_1.htm EX-32.1 14489
7 GRAPHIC img146372527_0.jpg GRAPHIC 12520
8 GRAPHIC img147296048_0.jpg GRAPHIC 5126
  Complete submission text file 0000950170-24-093880.txt   6396327

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ikna-20240630.xsd EX-101.SCH 842169
60 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20240630_htm.xml XML 870836
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 241188161
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)